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Introduction: Cutaneous amyloidosis refers to a rare group of skin
disease, which is characterized by the deposition of amyloid ma-
terial. Nodular localized cutaneous amyloidosis (NLCA) is the rarest
type of localized cutaneous amyloidosis. A 54-year-old woman
presented to the clinic with two lesions on the nose. We describe
the examinations that led to the diagnosis of NLCA and the
treatment given to her.
Methods: PubMed was used to ﬁnd literature about the treatment
of nodular amyloidosis. After carefully weighing different treat-
ment options and consulting colleagues, the shaving techniques
were considered the best treatment option for this patient.
Results: The shaving technique gave excellent results for this pa-
tient in treating the nodular localized cutaneous amyloidosis.
Conclusions: The shaving technique is a good treatment option for
patients with nodular localized cutaneous amyloidosis.
© 2015 The Authors. Published by Elsevier Ltd on behalf of British
Association of Plastic, Reconstructive and Aesthetic Surgeons. This
is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Cutaneous amyloidosis refers to a rare group of skin disease, which is characterized by the depo-
sition of amyloid material. Nodular localized cutaneous amyloidosis (NLCA) is the rarest type ofchelangelolaan 2, 5623 EJ Eindhoven, The Netherlands. Tel.: þ31 (0) 40
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cases have been reported in the North American, European and Asian literature. Numerous treatments
have been introduced in an attempt to improve the appearance of NLCA lesions, including shaving,
excision and split-skin grafting,1 dermabrasion,2 carbon dioxide laser,3 topical and intralesional cor-
ticosteroids, cryotherapy and pulsed dye laser.4
In this case report, we present a woman with a rare form of NLCA and the treatment given to her.Case report
A 54-year-old woman presented to the clinic with two lesions on the nose: one lesion on the right
side of the nose bridge and one on the left nostril, 1.5 cm and 0.7 cm, respectively (Figure 1). Further
examination of the lesions showed that they were skin-coloured to purpuric, waxy and eminent. The
patient had noticed the tumours for the ﬁrst time a few years earlier.
Her history revealed psoriasis and breast cancer, and she smoked 15 cigarettes a day. Her family
history for systemic diseases was negative.Background
Amyloid
Amyloid is a combined term for abnormal, insoluble, ﬁbrillar-formed, extracellular proteins that
share some important characteristics. The diagnosis of amyloid is established by biopsy. All amyloids
are eosinophilic, and they turn apple green when viewed under polarized lighting after staining with
Congo red.5 The classiﬁcation of amyloidosis can be based on the type of the precursor protein or on the
clinical classiﬁcation.6 The clinical classiﬁcation is an older classiﬁcation based on the clinical pre-
sentation of the patient, and it categorizes amyloidosis as primary, secondary, familial and isolated
amyloidosis. The ﬁrst three mentioned are usually, but not always, systemic diseases. IsolatedFigure 1. Detailed picture of the two marked lesions on the nose.
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protein. The common clinical amyloid entities are AL, AA, ATTR and Ab2M types. Both classiﬁcations are
still used.
Cutaneous amyloidosis
Cutaneous deposits of amyloid can be discerned in 29e40% of the cases with primary systemic
amyloidosis, but they are very rare in the other systemic types.
If the cutaneous amyloidosis appears not to be a symptom of a systemic amyloidosis, it is called a
primary localized cutaneous amyloidosis.
There are three types of primary localized cutaneous amyloidosis: nodular, macular and lichen
amyloidosis. Nodular amyloidosis is the rarest type.7 The main symptom of macular and lichen
amyloidosis is pruritus, and it is rarely seen in the nodular form (Table 1).
Nodular localized cutaneous amyloidosis
NLCA is most often benign and limited to the skin. Cases developing into a systemic disease are
described in series with small numbers of patients with rates varying from 7% to nearly 50%.8 Themean
age of onset has been reported to be 55 years, with a range from 33 to 86.
The cause of the disease is still unknown, but there seems to be an association between NLCA and
autoimmune disorders, such as CREST syndrome, rheumatoid arthritis, primary biliary cirrhosis and
systemic lupus erythematosus.9 In previous case reports, 25% of the patients had Sj€ogren
syndrome.10
Systemic amyloidosis
It is important to rule out systemic amyloidosis in a patient with NLCA, because systemic
amyloidosis is a progressive, incurable, metabolic disease in which amyloid deposits in one or more
organs tend to cause failure. The most common systemic amyloidosis is the AA form of amyloidosis; it
was formerly termed secondary amyloidosis.
The diagnosis of systemic amyloidosis can be made based on clinical features, studying the amyloid
protein types and imaging tests.
Treatment options
The treatment for NLCA is still experimental. As mentioned, several techniques have been used in an
attempt to treat NLCA in the best possible way. Unfortunately, none of these treatments totallyTable 1
Types and characteristics of cutaneous amyloidosis.
Type of
cutaneous
amyloidosis
Type of
amyloid
composition
Mostly affected
location on the body
Appearance of lesion Can be a sign of
systemic amyloidosis
Nodular AL amyloid Symmetrical noduli
on ears, joint cavities,
face, trunk, limbs,
genital area
Pink to brown red noduli Yes
Macular AK amyloid Back and shoulders Hyperpigmented skin with
an unsharp margin
No
Lichen AK amyloid Pretibial Multiple pink to brown hard
hyperkeratotic papules
No
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there is always a possibility of recurrence.Results
Before treatment, the patient was referred to a dermatologist. A 3-mm biopsy of the lesion on the
right side of the nose was performed. Microscopic examination has shown a homogeneous eosino-
philic stroma of the dermis with locally resembling colloid bodies. The stroma discoloured red under
Congo red staining and apple green when viewed with polarized light. This is typical for amyloid
deposits.
In this case, an internist excluded a systemic disease. Her family history for systemic diseases
was negative. This makes hereditary amyloidosis improbable, as it is an autosomal dominant dis-
ease, and age of onset is typically between 5 and 15 years. The pathology report of the biopsy
showed a non-AA type of amyloidosis, which excluded secondary amyloidosis. In order to exclude
primary systemic amyloidosis, additional examinations were done: chest radiography, abdominal
ultrasonography, urine and blood tests. These tests were normal, and they showed no indications
for a systemic component of amyloidosis. After exclusion of systemic amyloidosis, the diagnosis of
NLCA was made.
After a literature search and careful considerations consulting nine plastic surgeons at our monthly
outpatient consulting hour, the two lesions were shaved with a 15-blade knife and equalized by
dermabrasion. Haemostasis was well achieved. At 24 months follow-up, there were no signs of
recurrence or systemic disease (Figures 2 and 3).Figure 2. Patient 1 week after treatment.
Figure 3. Patient 6 months after treatment.
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In this case, systemic amyloidosis was excluded. In some cases, unfortunately, a local amyloidosis
has the tendency to progress to a systemic disease in at least 7%, and rates up to 50% have also been
reported. Because of this wide interval, the necessity for follow-up remains to be established.
The cause of NLCA is unknown, but it is associated with autoimmune disorders. Our patient has a
history of psoriasis. To our knowledge, this association has never been described in the literature.
Different treatment options were considered. Because of the size and location of the noduli, primary
excision and closure was not an option without leaving massive scars. Laser therapy was also
considered, but it was not used in view of the thickness of the noduli. Moreover, haemostasis problems
during a laser intervention were described in a previous case report with a nasal lesion. Dermabrasion
was performed.
Conclusion
When a nodular skin lesion is present in a patient with an autoimmune disorder, an amyloid
deposition should be considered. If a biopsy conﬁrms amyloid deposition, it is necessary to exclude a
systemic cause. If the diagnosis of NLCA is established, follow-up of the patient after treatment should
be performed.
Treatment of NLCA is still experimental, and recurrences have been mentioned. In this experience,
the shaving technique is a good treatment option for patients with NLCA.
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